(Q42508969)

English

Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

author name string

Barbara J McDermott

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Stewart McWilliams

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Karen Smyth

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Elizabeth J Kelso

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

J Paul Spiers

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

YouYou Zhao

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

David Bell

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Rajinder K Mirakhur

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

27 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

600-608

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

New concepts in reactive oxygen species and cardiovascular reperfusion physiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Protection of the myocardial cell during ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol. An update of its use in anaesthesia and conscious sedation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol and ketamine only inhibit intracellular Ca2+ transients and contraction in rat ventricular myocytes at supraclinical concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

The antioxidant potential of propofol (2,6-diisopropylphenol).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Inotropic response to endothelin-1, isoprenaline and calcium in cardiomyocytes isolated from endotoxin treated rats: effects of ethyl-isothiourea and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Rapid assay of adenine nucleotides or creatine compounds in extracts of cardiac tissue by paired-ion reverse-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

A simple, rapid, and sensitive DNA assay procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Regulation of protein synthesis and degradation in adult ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

The ischemic heart--experimental models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Abnormalities of the myocytes in ischaemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Myocyte adaptation to chronic hypoxia and development of tolerance to subsequent acute severe hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol: therapeutic indications and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol increases phosphorylation of troponin I and myosin light chain 2 via protein kinase C activation in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Effects of propofol on contractile response and electrophysiological properties in single guinea-pig ventricular myocyte.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Propofol attenuates beta-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Inhibition by verapamil and diltiazem of agonist-stimulated contractile responses in mammalian ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Specificity and properties of propofol as an antioxidant free radical scavenger.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Increase in antioxidant capacity of plasma during propofol anesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Inhibition of cardiac myocyte contraction by 4-hydroxy-trans-2-nonenal

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

Effect of propofol on in vitro lipid peroxidation induced by different free radical generating systems: a comparison with vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.12.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YJMCC.2006.12.002

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42508969&oldid=1960166134"